Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/26/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Nicholas P. Plotnikoff

Wrong Dr. Nicholas P. Plotnikoff?

Professor

Phone: (217) ***-****  HQ Phone
Local Address:  Chicago , Illinois , United States
University of Illinois
1101 West Peabody Drive
Urbana , Illinois 61801
United States

Company Description: The University of Illinois at Urbana–Champaign (U of I, University of Illinois, UIUC, or simply Illinois) is a public research-intensive university in the U.S....   more
Background

Employment History

Education

  • American Board of Toxicology
  • Ph.D.
    China Medical University
47 Total References
Web References
LDN: The Latest News
www.lowdosenaltrexone.org [cached]
Dr. Nicholas Plotnikoff, Chairman of TNI BioTech, recently announced that his company has acquired all of Dr. Bernard Bihari's use-patents for low dose naltrexone.
...
Dr. Plotnikoff, quoted on the TNI BioTech website, said:
...
Dr. Plotnikoff, Emeritus Professor of Pharmacology and Psycho­neuro­immuno­logy, College of Pharmacy and College of Medicine, at the University of Illinois in Chicago, holds a PhD in Pharmacology. Prior to TNI, Dr. Plotnikoff helped direct research for Abbott Labs.
...
Following welcoming remarks from Jeffrey Abrams, MD, Chief of the Clinical Investigations Branch of the NCI, speakers included David Gluck, MD (Introductory Overview); Jill Smith, MD (Clinical Experience with LDN in Crohn's Disease; Opioid Growth Factor in Pancreatic Cancer); John Hong, PhD (Anti-Inflammatory and Neuroprotective Effects of Naltrexone and Its Analogs); Nicholas Plotnikoff, PhD (Overview of Metenkephalin Actions in HIV Infections); Burton M. Berkson, MD, PhD (Personal Experiences with LDN for Various Cancers); Maira Gironi, MD, PhD and Filippo M. Boneschi, MD, PhD (Ongoing Pilot Study of LDN in MS: Preliminary Findings).
...
Invitees thus far include I. Zagon, PhD; Jill P. Smith, MD; John Hong, PhD; and Nicholas Plotnikoff, PhD; as well as physician practitioners with experiences in LDN treatment.
LDN: The Latest News
www.ldninfo.org [cached]
Dr. Nicholas Plotnikoff, Chairman of TNI BioTech, recently announced that his company has acquired all of Dr. Bernard Bihari's use-patents for low dose naltrexone.
...
Dr. Plotnikoff, quoted on the TNI BioTech website, said:
...
Dr. Plotnikoff, Emeritus Professor of Pharmacology and Psycho­neuro­immuno­logy, College of Pharmacy and College of Medicine, at the University of Illinois in Chicago, holds a PhD in Pharmacology. Prior to TNI, Dr. Plotnikoff helped direct research for Abbott Labs.
...
Following welcoming remarks from Jeffrey Abrams, MD, Chief of the Clinical Investigations Branch of the NCI, speakers included David Gluck, MD (Introductory Overview); Jill Smith, MD (Clinical Experience with LDN in Crohn's Disease; Opioid Growth Factor in Pancreatic Cancer); John Hong, PhD (Anti-Inflammatory and Neuroprotective Effects of Naltrexone and Its Analogs); Nicholas Plotnikoff, PhD (Overview of Metenkephalin Actions in HIV Infections); Burton M. Berkson, MD, PhD (Personal Experiences with LDN for Various Cancers); Maira Gironi, MD, PhD and Filippo M. Boneschi, MD, PhD (Ongoing Pilot Study of LDN in MS: Preliminary Findings).
...
Invitees thus far include I. Zagon, PhD; Jill P. Smith, MD; John Hong, PhD; and Nicholas Plotnikoff, PhD; as well as physician practitioners with experiences in LDN treatment.
Vector Medical Technologies, Inc.
www.vectormedtech.com [cached]
Nicholas P. Plotnikoff , Ph.D. has served as Vice President of Research and Development of the Company since January 1999.He has over 20 years of experience in the pharmaceutical industry working in pharmacology , toxicology and clinical research.Dr. Plotnikoff is Professor at the University of Illinois , College of Pharmacy and College of Medicine.Dr. Plotnikoff is the founder , Chairman , and Chief Executive Officer of TNI Pharmaceuticals , Inc..
Vice President of Sales and Marketing
PREVENTING AIDS WITH LDN IN MALI, AFRICA
www.ldnafricaaids.org [cached]
Dr. Nicholas Plotnikoff, Chairman of TNI BioTech, recently announced that his company has acquired all of Dr. Bernard Bihari's use-patents for low dose naltrexone.
Board of Directors
www.tnibiotech.com [cached]
Dr. Nicholas Plotnikoff, Non-Executive Chairman ?
...
Dr. Plotnikoff has a Ph.D. in Pharmacology, with over 20 years in the pharmaceutical industry, working in Pharmacology, Toxicology, and Clinical Research. Dr. Plotnikoff was a Professor of Pharmacology at the University of Illinois Medical Center in Chicago. Dr. Plotnikoff played a pioneering role in investigations of the immunological effects of MENK. He also successfully managed the project teams that developed the NDAs on Traxene (Valium-like tranquilizer) and Cylert (non-amphetamine psychostimulant).
In basic research he was the first to identify the central nervous system effects of hypothalamic releasing factors (brain hormones), resulting in their clinical development for treatment of depression and Parkinson's disease. Dr. Plotnikoff co-authored 25 publications with Dr. Andrew Schally covering basic research in the field of depression and Parkinson's disease.
...
Dr. Plotnikoff held a number of international patents for the use of MENK in HIV/AIDS and cancer.
Other People with the name "Plotnikoff":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304